Retour
Fourchette du Jour
17,32 €
17,94 €
Fourchette 52 Semaines
16,10 €
30,48 €
Volume
2 408 487
Moyenne 50J / 200J
21,38 €
/
22,48 €
Clôture Précédente
17,21 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 100,3 | 0,4 |
| P/B | 6,1 | 2,9 |
| ROE % | 7,5 | 3,7 |
| Net Margin % | 2,2 | 3,8 |
| Rev Growth 5Y % | 97,1 | 10,0 |
| D/E | 1,3 | 0,2 |
Points Clés
Revenue grew 97,06% annually over 5 years — strong growth
Generating 45,01M in free cash flow
P/E of 100,32 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 68,60%
Cash machine — converts 201,06% of earnings into free cash flow
Capital efficient — spends only 0,03% of revenue on capex
Croissance
Revenue Growth (5Y)
97,06%
Revenue (1Y)28,46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
7,48%
ROIC4,85%
Net Margin2,23%
Op. Margin5,52%
Sécurité
Debt / Equity
1,31
Current Ratio3,14
Interest Coverage1,25
Valorisation
P/E Ratio
100,32
P/B Ratio6,07
EV/EBITDA40,86
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28,46% | Revenue Growth (3Y) | 59,09% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 97,06% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,00B | Net Income (TTM) | 22,39M |
| ROE | 7,48% | ROA | 2,08% |
| Gross Margin | 89,81% | Operating Margin | 5,52% |
| Net Margin | 2,23% | Free Cash Flow (TTM) | 45,01M |
| ROIC | 4,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,31 | Current Ratio | 3,14 |
| Interest Coverage | 1,25 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 100,32 | P/B Ratio | 6,07 |
| P/S Ratio | 2,24 | PEG Ratio | -1,27 |
| EV/EBITDA | 40,86 | Dividend Yield | 0,00% |
| Market Cap | 2,25B | Enterprise Value | 2,26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,00B | 781,37M | 396,59M | 75,42M | 66,56M |
| Net Income | 22,39M | -197,88M | -528,63M | -652,17M | -746,35M |
| EPS (Diluted) | 0,18 | -1,60 | -4,45 | -6,15 | -8,84 |
| Gross Profit | 901,55M | 663,64M | 338,08M | 69,79M | 61,36M |
| Operating Income | 55,43M | -164,98M | -517,12M | -594,61M | -536,28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,08B | 885,05M | 788,73M | 760,22M | 881,77M |
| Total Liabilities | 705,11M | 656,51M | 594,21M | 590,35M | 683,10M |
| Shareholders' Equity | 370,15M | 228,54M | 194,52M | 169,87M | 198,66M |
| Total Debt | 486,31M | 469,78M | 110,93M | 112,71M | 210,22M |
| Cash & Equivalents | 467,76M | 411,29M | 351,19M | 551,80M | 640,19M |
| Current Assets | 1,01B | 788,95M | 766,33M | 719,52M | 824,05M |
| Current Liabilities | 323,60M | 185,51M | 247,59M | 167,61M | 131,85M |